C

Celladon Corporation

2 employees

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Hospital

Date founded

2000

Funding rounds raised

Total raised

$43M

from 11 investors over 11 rounds

C

Celladon Corporation raised $40M on November 18, 2015

Investors: Vivo Capital, RA Capital Management, L.P., InterWest Partners and Perceptive Advisors

C

Celladon Corporation raised $10M on May 8, 2012

Investors: EQT Life Sciences and MPM Capital

C

Celladon Corporation raised $43M on February 15, 2012

Investors: Lundbeckfonden / Lundbeck Foundation, Venrock and GBS Venture Partners

C

Celladon Corporation raised $22M on November 1, 2009

Investors: Enterprise Partners Venture Capital and Venrock

FAQ